Checkpoint Capital L.P. Portfolio Holdings

Checkpoint Capital L.P.

  • $298 Billion
  • Q3 2025

Checkpoint Capital L.P. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $298 Billion distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $111B, Rhythm Pharmaceuticals, Inc. with a value of $77.1B, Corcept Therapeutics Inc with a value of $32.6B, Disc Medicine Inc with a value of $28.4B, and Revolution Medicines, Inc. with a value of $23B.

Examining the 13F form we can see an increase of $83.9B in the current position value, from $215B to 298B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.

Portfolio value $298 Billion
Healthcare: $265 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $298 Billion
  • Prior Value $215 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 3 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email